The emotional aftermath of childhood cancer treatment can be as profound and lasting as the physical challenges faced during the illness. A groundbreaking study featured in the esteemed journal, Pediatric Research, unveils a troubling reality: long after treatment concludes, many young cancer survivors and their parents continue to grapple with significant emotional distress, including symptoms of post-traumatic stress disorder (PTSD), anxiety, and depression. This underscores the enduring psychological effects that pediatric cancer can impose.
Led by Maya Yardeni, a doctoral candidate at Bar-Ilan University and an experienced psychologist within the Pediatric Hemato-Oncology Division at Sheba Medical Center, this research was co-supervised by notable figures in psychology, Professor Ilanit Hasson-Ohayon and Professor Dalit Modan-Moses. Their findings shine a light on the fact that trauma can arise not only from overtly violent events but also from the fear and invasive medical procedures associated with prolonged illnesses, frequent hospital stays, and the uncertainty that follows such experiences.
"Even when treatment is completed, the psychological burden for children and their caregivers remains substantial," noted Prof. Hasson-Ohayon, who leads the Rehabilitation Psychology Lab at Bar-Ilan University. "Pediatric cancer creates a shared journey fraught with unpredictability and fear. Our research highlights the urgent need for continuous emotional support and screening for both children and their parents well beyond the initial recovery phase."
The experience of pediatric cancer is uniquely collective, as parents often accompany their children through every step of the illness. This shared ordeal fosters a persistent sense of threat and a feeling of losing control over life’s circumstances. As days turn into months, this collective exposure can yield long-lasting psychological repercussions for both survivors and their families, even when the medical battle has been won.
To delve deeper into this issue, the researchers executed a cross-sectional study involving 118 childhood cancer survivors aged between 7 and 21 years old, along with their parents, all of whom had completed treatment at least a year prior. They utilized validated questionnaires to assess levels of PTSD, anxiety, and depression, gathering comprehensive medical and demographic data from medical records. This dual approach allowed for a rich comparison between how children perceive their emotional states and how their parents interpret those feelings.
The results reveal a strikingly high prevalence of psychological distress among survivors during what is known as the survivorship phase—the time following the end of treatment. Symptoms of trauma, anxiety, and depression were found to be intricately linked. Interestingly, the study revealed that the parents' perceptions of their children's emotional struggles were often more closely aligned with the parents' own mental health rather than the children's self-reported feelings. This suggests that a parent's emotional well-being can significantly influence how they understand and interpret their child's psychological state.
Beyond its contributions to scientific knowledge, this research carries vital clinical implications. It calls for an evolution in long-term follow-up care within pediatric oncology, advocating for a holistic approach that encompasses not just physical health but also the ongoing psychological assessments of both children and parents. By prioritizing children's perspectives and providing targeted psychosocial support throughout their survivorship journey, healthcare providers can enhance long-term family outcomes significantly.
Building on these important insights, the research team is embarking on a follow-up study aimed at evaluating the effectiveness of trauma-focused psychotherapy for the parents of childhood cancer survivors. This initiative seeks to alleviate long-term trauma symptoms and foster improved emotional well-being for families as they navigate the aftermath of cancer treatment.
This impactful study received funding from a grant awarded by the Israel Cancer Association.
